EIF3A and cancer: This may suggest that the observed pathological effects often attributed to alterations in the expression levels of a single eIF3 subunit are actually caused not only by the lack or excessive amount of this particular subunit per se, but by the loss or gain of function of partial eIF3 subcomplexes that could form in cancer and other sick cells as a result of these expression anomalies.